National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Mark J. Niciu; Robert C. Meisner; Brent R. Carr; Ali A. Farooqui; David Feifel; Adam Kaplin; E. Jeremy Kendrick; Paul M. Kim; Christopher D. Schneck; Jennifer L. Vande Voort; Sagar V. Parikh

doi:10.1016/j.jad.2023.11.008

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

Mark J. Niciu
, Robert C. Meisner
, Brent R. Carr
, Ali A. Farooqui
, David Feifel
, Adam Kaplin
, E. Jeremy Kendrick
, Paul M. Kim
, Christopher D. Schneck
, Jennifer L. Vande Voort
, Sagar V. Parikh

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	221-222
Number of pages	2
Journal	Journal of Affective Disorders
Volume	346
DOIs	https://doi.org/10.1016/j.jad.2023.11.008
State	Published - Feb 1 2024

ASJC Scopus subject areas

Psychiatry and Mental health
Clinical Psychology

Access to Document

10.1016/j.jad.2023.11.008

Cite this

Niciu, M. J., Meisner, R. C., Carr, B. R., Farooqui, A. A., Feifel, D., Kaplin, A., Kendrick, E. J., Kim, P. M., Schneck, C. D., Vande Voort, J. L., & Parikh, S. V. (2024). National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder. Journal of Affective Disorders, 346, 221-222. https://doi.org/10.1016/j.jad.2023.11.008

Niciu, MJ, Meisner, RC, Carr, BR, Farooqui, AA, Feifel, D, Kaplin, A, Kendrick, EJ, Kim, PM, Schneck, CD, Vande Voort, JL & Parikh, SV 2024, 'National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder', Journal of Affective Disorders, vol. 346, pp. 221-222. https://doi.org/10.1016/j.jad.2023.11.008

@article{2f3346bd582141079c032e4f1fbac431,

title = "National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder",

author = "Niciu, \{Mark J.\} and Meisner, \{Robert C.\} and Carr, \{Brent R.\} and Farooqui, \{Ali A.\} and David Feifel and Adam Kaplin and Kendrick, \{E. Jeremy\} and Kim, \{Paul M.\} and Schneck, \{Christopher D.\} and \{Vande Voort\}, \{Jennifer L.\} and Parikh, \{Sagar V.\}",

year = "2024",

month = feb,

day = "1",

doi = "10.1016/j.jad.2023.11.008",

language = "English (US)",

volume = "346",

pages = "221--222",

journal = "Journal of Affective Disorders",

issn = "0165-0327",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - National Network of Depression Centers position statement

T2 - Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

AU - Niciu, Mark J.

AU - Meisner, Robert C.

AU - Carr, Brent R.

AU - Farooqui, Ali A.

AU - Feifel, David

AU - Kaplin, Adam

AU - Kendrick, E. Jeremy

AU - Kim, Paul M.

AU - Schneck, Christopher D.

AU - Vande Voort, Jennifer L.

AU - Parikh, Sagar V.

PY - 2024/2/1

Y1 - 2024/2/1

UR - https://www.scopus.com/pages/publications/85176758581

UR - https://www.scopus.com/pages/publications/85176758581#tab=citedBy

U2 - 10.1016/j.jad.2023.11.008

DO - 10.1016/j.jad.2023.11.008

M3 - Letter

C2 - 37940059

AN - SCOPUS:85176758581

SN - 0165-0327

VL - 346

SP - 221

EP - 222

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

ER -

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this